Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy by Globahan Ajibola, Christopher Rowley, Dorcas Maruapula, Jean Leidner, Kara Bennett, Kathleen Powis, Roger L. Shapiro, Shahin Lockman

Connect to this object online.

High risk of adverse birth outcomes among adolescents living with HIV in Botswana compared to adult women living with HIV and adolescents without HIV by Maya Jackson-Gibson, Rebecca Zash, Aamirah Mussa, Ellen C. Caniglia, Modiegi Diseko, Gloria Mayondi, Judith Mabuta, Chelsea Morroni, Mompati Mmalane, Shahin Lockman, Joseph Makhema, Roger L. Shapiro

Connect to this object online.

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana by Kathleen M. Powis, Shahin Lockman, Gbolahan Ajibola, Michael D. Hughes, Kara Bennett, Jean Leidner, Oganne Batlang, Kerapetse Botebele, Sikhulile Moyo, Erik van Widenfelt, Joseph Makhema, Chipo Petlo, Haruna B. Jibril, Kenneth McIntosh, Max Essex, Roger L. Shapiro

Connect to this object online.

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study by Rebecca Zash, MD, Denise L Jacobson, PhD, Modiegi Diseko, BA, Gloria Mayondi, BSc, Mompati Mmalane, MD, Max Essex, ProfPhD, Tendani Gaolethe, MD, Chipo Petlo, BA, Shahin Lockman, MD, Lewis B Holmes, MD, Joseph Makhema, MBBS, Roger L Shapiro, MD

Connect to this object online.